This FOA solicits Specialized Center Cooperative Agreement (U54) applications to provide support for Medications Development Centers of Excellence (MDCE) with emphasis on clinical research directed towards the identification, evaluation, and development of safe and effective medications and biologics for treatment of substance use disorders (SUDs). Research may focus on both currently approved or novel, investigational products. Centers may have a translational component to reinforce rationale of medications for testing.
Only one application per institution is allowed.
NIDA intends to fund an estimate of 2 cooperative agreement awards, corresponding to a total of $3 M, for fiscal year 2014. Future year amounts will depend on annual appropriations. Application budgets are limited to $1M in direct costs. Applicants may apply for up to five years of support.
Internal Selection Procedure
Admin/Reviewer Login here first
Back to the WINS main page